Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nadia Reyna

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
American Journal of Therapeutics|April 7, 2007
Effect of cigarette smoking on the oxidant/antioxidant balance in healthy subjectsJennifier Chávez, Clímaco Cano, Aida Souki, et al.
American Journal of Therapeutics|January 14, 2010
The Maracaibo city metabolic syndrome prevalence study: design and scopeValmore Bermúdez, Rafael París Marcano, Clímaco Cano, et al.
American Journal of Therapeutics|April 7, 2007
Ciprofibrate treatment decreases non-high density lipoprotein cholesterol and triglycerides and increases high density lipoprotein cholesterol in patients with Frederickson type IV dyslipidemia phenotypeValmore Bermúdez-Pirela, Aida Souki, Clímaco Cano-Ponce, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
American Journal of Therapeutics|April 7, 2007
Effect of cigarette smoking on the oxidant/antioxidant balance in healthy subjectsJennifier Chávez, Clímaco Cano, Aida Souki, et al.
American Journal of Therapeutics|January 14, 2010
The Maracaibo city metabolic syndrome prevalence study: design and scopeValmore Bermúdez, Rafael París Marcano, Clímaco Cano, et al.
American Journal of Therapeutics|April 7, 2007
Ciprofibrate treatment decreases non-high density lipoprotein cholesterol and triglycerides and increases high density lipoprotein cholesterol in patients with Frederickson type IV dyslipidemia phenotypeValmore Bermúdez-Pirela, Aida Souki, Clímaco Cano-Ponce, et al.
Pageof 3